NCT02738021

Brief Summary

A Stepped Care pathway for managing postpartum depression (PPD) in pediatric primary care settings will be used to (1) understand context for implementation feasibility (2) evaluate benefits for mother and child. The proposed pilot project will be conducted as part of a quality improvement effort in the Department of Pediatrics at Gouverneur Health Services to improve management of postpartum depression during pediatric primary care visits. This project will test the feasibility of a stepped care approach to identifying and managing depression among mothers of infants (0-6 months). This study will provide preliminary data on the feasibility of the care management protocol, implementation and fidelity measures, and training/consultation methods within a real world pediatric care practice. These data will inform and support the preparation of a large-scale NIH grant. Specific research questions include:

  1. 1.To pilot the feasibility of using a Stepped Care Approach to identify and mange maternal depression within primary care pediatric care visits, with a focus on mothers of infants 0-6 months.
  2. 2.Train non specialty MH providers to systematically identify maternal depression.
  3. 3.Assess how effective integration of maternal depression intervention is as part of well baby visits.
  4. 4.To o examine the impact of STRONG, a brief 3-session IPT-based preventive intervention, on maternal and child health outcomes (e.g., maternal depression symptoms, child receipt of acute care services). Secondary outcomes include maternal social support and parenting practices.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Mar 2016

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2016

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

April 8, 2016

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 14, 2016

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2017

Completed
Last Updated

December 6, 2017

Status Verified

December 1, 2017

Enrollment Period

1.6 years

First QC Date

April 8, 2016

Last Update Submit

December 4, 2017

Conditions

Keywords

PsychosocialPsychotherapyMaternal

Outcome Measures

Primary Outcomes (1)

  • Patient Health Questionnaire-9 (PHQ-9)

    A validated 9-item self-administered version of the PRIME-MD that assesses depression severity.

    One year

Secondary Outcomes (1)

  • Maternal Depression Management Inventory

    One year

Study Arms (1)

STRONG

EXPERIMENTAL

A brief 3-session IPT-based preventive intervention, on maternal and child health outcomes.

Behavioral: STRONG

Interventions

STRONGBEHAVIORAL

A brief 3-session IPT-based preventive intervention, on maternal and child health outcomes.

STRONG

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • PHQ-9 scores in the 10-19 range
  • Women with infants 6 months and younger at time of screening

You may not qualify if:

  • Active substance use
  • Current treatment for depression
  • Current/past history of schizophrenia, bipolar or other psychotic disorder;
  • Suicidal/Homicidal risks;
  • Women with difficulties speaking or understanding English;
  • Women under the age of 18.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Depression, Postpartum

Condition Hierarchy (Ancestors)

Puerperal DisordersPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDepressive DisorderMood DisordersMental Disorders

Study Officials

  • Serene Olin, PhD

    NYU Langone Health

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 8, 2016

First Posted

April 14, 2016

Study Start

March 1, 2016

Primary Completion

October 1, 2017

Study Completion

October 1, 2017

Last Updated

December 6, 2017

Record last verified: 2017-12